Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) will be presenting at and attending several major conferences in September, October, and November 2024, showcasing its progress in cancer immunotherapy development. Key events include the ADC & Radiopharmaceuticals Summit in Boston (September 9-10), ESMO Congress in Barcelona (September 13-17), and the Vaccines & Immunotherapies Online Symposium (September 26). Additionally, Scancell will participate in the Festival of Biologics in Basel (October 15-17) and the PEGS Europe conference in Barcelona (November 5-7). For more information click here.
Advertisement Go to Proactive UK Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com